

MaxCyte Inc (NASDAQ: MXCT) shares are trading higher by over 9% after the company disclosed strong preliminary Q4 and full-year
You can purchase shares of MaxCyte (NASDAQ:MXCT) through any online brokerage.
Other companies in MaxCyte’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
MaxCyte has a consensus price target of $7.75.
The stock price for MaxCyte (NASDAQ: MXCT) is $1.25 last updated November 6, 2026 at 5:33 PM EST.
There are no upcoming dividends for MaxCyte.
MaxCyte does not have any upcoming earnings scheduled.
There is no upcoming split for MaxCyte.
MaxCyte is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical...